No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.
| Authors | Panagiotis Baliakas, Mattias Mattsson, Anastasia Hadzidimitriou, Eva Minga, Andreas Agathangelidis, Lesley-Ann Sutton, Lydia Scarfo, Zadie Davis, Xiao-Jie Yan, Karla Plevova, Yorick Sandberg, Fie J Vojdeman, Tatiana Tzenou, Charles C Chu, Silvio Veronese, Larry Mansouri, Karin E Smedby, Véronique Giudicelli, Florence Nguyen-Khac, Panagiotis Panagiotidis, Gunnar Juliusson, Achilles Anagnostopoulos, Marie-Paule Lefranc, Livio Trentin, Mark Catherwood, Marco Montillo, Carsten U Niemann, Anton W Langerak, Sarka Pospisilova, Niki Stavroyianni, Nicholas Chiorazzi, David Oscier, Diane F Jelinek, Tait Shanafelt, Nikos Darzentas, Chrysoula Belessi, Frederic Davi, Paolo Ghia, Richard Rosenquist, Kostas Stamatopoulos |
| Journal | Haematologica
(Haematologica)
Vol. 103
Issue 4
Pg. e158-e161
(04 2018)
ISSN: 1592-8721 [Electronic] Italy |
| PMID | 29269523
(Publication Type: Letter, Research Support, Non-U.S. Gov't)
|
| Topics |
- Adult
- Aged
- Aged, 80 and over
- Drug Therapy
(mortality)
- Female
- Humans
- Immunotherapy
(mortality)
- Leukemia, Lymphocytic, Chronic, B-Cell
(drug therapy, mortality)
- Male
- Middle Aged
- Retrospective Studies
- Survival Rate
- Young Adult
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
